ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 855,22
1,54%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Turning Point Therapeutics Inc (TPTX)

  7. Turning Point Therapeutics Inc (TPTX) Actualités

TPTX

Turning Point Therapeutics (TPTX)

Turning Point Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TPTX
DateHeureSourceTitreSymboleSociété
29/08/202222h31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TPTXTurning Point Therapeutics Inc
23/08/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202222h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202214h45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202213h09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202212h59Business WireBristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point TherapeuticsNASDAQ:TPTXTurning Point Therapeutics Inc
11/08/202205h20TipRanksAnalysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)NASDAQ:TPTXTurning Point Therapeutics Inc
10/08/202206h35TipRanksJMP Securities Remains a Hold on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202222h17GlobeNewswire Inc.Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesNASDAQ:TPTXTurning Point Therapeutics Inc
01/08/202205h31TipRanksSVB Securities Maintains a Hold Rating on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
27/07/202222h05GlobeNewswire Inc.Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCNASDAQ:TPTXTurning Point Therapeutics Inc
24/06/202215h00GlobeNewswire Inc.Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer TherapiesNASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202222h47Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202222h44Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TPTXTurning Point Therapeutics Inc
14/06/202204h05TipRanksAnalysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
06/06/202213h38TipRanksWhy Are Bristol-Myers & Turning Point Made for Each Other?NASDAQ:TPTXTurning Point Therapeutics Inc
06/06/202206h25TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bicycle Therapeutics (BCYC), Turning Point Therapeutics (TPTX) and Globus Medical (GMED)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202223h16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202216h36Dow Jones NewsTurning Point Therapeutics Shares Surge on Bristol Myers DealNASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202215h06Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202213h43Dow Jones NewsBristol Myers to Buy Turning Point Therapeutics for $4.1 BillionNASDAQ:TPTXTurning Point Therapeutics Inc
26/05/202222h30GlobeNewswire Inc.Turning Point Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:TPTXTurning Point Therapeutics Inc
16/05/202214h30GlobeNewswire Inc.Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial OfficerNASDAQ:TPTXTurning Point Therapeutics Inc
12/05/202206h25TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Concert Pharma (CNCE), Clearside Biomedical (CLSD) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
11/05/202214h43TipRanksSVB Securities Thinks Turning Point Therapeutics’ Stock is Going to RecoverNASDAQ:TPTXTurning Point Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPTX

Dernières Valeurs Consultées

EU
HO
Thales
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
EU
PX4
SBF 120
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
EU
RNO
Renault
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
EU
EN
Bouygues
NYSE
MRK
Merck
EU
AF
Air FranceKLM
FTSE
UKX
FTSE 100
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés